Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICF4
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0003723 | RNA binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 69 | 73 | PF00656 | 0.543 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.555 |
CLV_NRD_NRD_1 | 239 | 241 | PF00675 | 0.582 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.482 |
CLV_PCSK_FUR_1 | 92 | 96 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.426 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.480 |
CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.594 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.457 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.426 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.565 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.547 |
CLV_Separin_Metazoa | 23 | 27 | PF03568 | 0.596 |
DEG_APCC_DBOX_1 | 5 | 13 | PF00400 | 0.438 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.502 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.530 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.745 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.785 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.560 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.360 |
DOC_USP7_UBL2_3 | 237 | 241 | PF12436 | 0.592 |
DOC_USP7_UBL2_3 | 253 | 257 | PF12436 | 0.547 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.482 |
DOC_WW_Pin1_4 | 173 | 178 | PF00397 | 0.574 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.548 |
LIG_Actin_WH2_2 | 56 | 73 | PF00022 | 0.545 |
LIG_BIR_III_4 | 41 | 45 | PF00653 | 0.443 |
LIG_deltaCOP1_diTrp_1 | 107 | 117 | PF00928 | 0.505 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.521 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.436 |
LIG_FHA_2 | 234 | 240 | PF00498 | 0.630 |
LIG_LIR_Apic_2 | 73 | 79 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.570 |
LIG_PROFILIN_1 | 227 | 233 | PF00235 | 0.799 |
LIG_SH2_CRK | 142 | 146 | PF00017 | 0.510 |
LIG_SH2_NCK_1 | 142 | 146 | PF00017 | 0.487 |
LIG_SH2_NCK_1 | 76 | 80 | PF00017 | 0.544 |
LIG_SH2_SRC | 165 | 168 | PF00017 | 0.739 |
LIG_SH2_SRC | 76 | 79 | PF00017 | 0.548 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.600 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.487 |
LIG_SH2_STAP1 | 84 | 88 | PF00017 | 0.556 |
LIG_SH3_2 | 232 | 237 | PF14604 | 0.649 |
LIG_SH3_3 | 224 | 230 | PF00018 | 0.690 |
LIG_SUMO_SIM_par_1 | 59 | 65 | PF11976 | 0.522 |
LIG_TRAF2_1 | 236 | 239 | PF00917 | 0.606 |
MOD_CDK_SPK_2 | 128 | 133 | PF00069 | 0.482 |
MOD_CK1_1 | 213 | 219 | PF00069 | 0.784 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.470 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.639 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.727 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.669 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.474 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.561 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.409 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.560 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.775 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.528 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.523 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.498 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.502 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.469 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.544 |
MOD_NEK2_2 | 66 | 71 | PF00069 | 0.462 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.436 |
MOD_PKA_1 | 240 | 246 | PF00069 | 0.571 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.779 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.547 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.509 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.545 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.477 |
MOD_ProDKin_1 | 173 | 179 | PF00069 | 0.577 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.553 |
MOD_SUMO_rev_2 | 234 | 243 | PF00179 | 0.604 |
MOD_SUMO_rev_2 | 37 | 46 | PF00179 | 0.530 |
TRG_DiLeu_BaEn_1 | 20 | 25 | PF01217 | 0.538 |
TRG_DiLeu_BaEn_4 | 101 | 107 | PF01217 | 0.553 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.396 |
TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.576 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.459 |
TRG_ER_diArg_1 | 25 | 28 | PF00400 | 0.459 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.452 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.478 |
TRG_ER_diLys_1 | 253 | 258 | PF00400 | 0.638 |
TRG_Pf-PMV_PEXEL_1 | 10 | 14 | PF00026 | 0.519 |
TRG_Pf-PMV_PEXEL_1 | 19 | 23 | PF00026 | 0.383 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXA6 | Leptomonas seymouri | 68% | 92% |
A0A0S4JT72 | Bodo saltans | 44% | 100% |
A0A3Q8IJE0 | Leishmania donovani | 100% | 100% |
A0A422NCV8 | Trypanosoma rangeli | 44% | 93% |
A4HPB4 | Leishmania braziliensis | 78% | 100% |
D0A3C3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 96% |
E9AT25 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q1H3 | Leishmania major | 92% | 100% |
V5D8K3 | Trypanosoma cruzi | 46% | 97% |